Spontaneous pregnancy after prepubertal haematopoietic cell transplantation

Eek Chaw Tan; Hemashree Rajesh

doi:10.18203/2320-1770.ijrcog20180921

Authors

Eek Chaw Tan Department of Obstetrics and Gynecology, Singapore General Hospital, Singapore
Hemashree Rajesh Department of Obstetrics and Gynecology, Singapore General Hospital, Singapore

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20180921

Keywords:

Hematopoietic cell transplantation, Prepubertal, Spontaneous pregnancy

Abstract

Spontaneous pregnancy after haematopoietic cell transplantation (HCT) is rare due to an increase incidence of premature ovarian failure resulting from pre-transplantation conditioning regimes. Increased number of long term survival of HCT patients has brought forth their fertility into focus. In this article, we reported a 34 years old woman who underwent HCT at prepubertal age and had a spontaneous pregnancy. In addition, we reviewed literature on fertility outcome in HCT survivors and the associated risk factors.

Metrics

Metrics Loading ...

References

Khouri IF, Keating M, Körbling M, Przepiorka D, Anderlini P, O'Brien S, et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol 1998; 16:2817.

Champlin R, Khouri I, Shimoni A. Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy. Br J Haematol. 2000;111:18.

Giralt S, Ballen K, Rizzo D. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 2009;15:367.

Bacigalupo A, Ballen K, Rizzo D. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009;15:1628.

Loren AW, Chow E, David A. Jacobsohn. Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the center for international blood and marrow transplant research (CIBMTR). Biol Bone Marrow Transplant. 2011;1:157-66.

Carter A, Robison LL, Francisco L. Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the bone marrow transplant survivor study. Bone Marrow Transplant. 2006;37:1023-9.

Salooja N, Szydlo RM, Socie G. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet. 2001;358:271-6.

Sklar CA, Kim TH, Williamson JF, Ramsay NKC. Ovarian function after successful bone marrow transplantation in postmenarcheal females. Med Pediatr Oncol. 1983; 1:361-4.

Sanders JE, Hawley J, Levy W, Gooley T, Buckerner CD, Deeg HJ, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood. 1996;87:3045-52.

Sanders JE, Buckner CD, Leonard JM. Late effects on gonadal function of cyclophosphamides, total-body irradiation, and marrow transplantation. Transplant. 1983;36:252-5.

Mertens AC, Ramsay NK, Kouris S, Neglia JP. Patterns of gonadal dysfunction following bone marrow transplantation. Bone Marrow Transplant. 1998;22:345-50.

Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update. 2001;7:535-43.

Austin III HA, Klippel JH, Balow JE. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med. 1986;314:614-9.

Boumpas DT, Austin III HA, Vaughan EM. Controlled trial of pulsemethylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet. 1992;340:741-5.

Illei GG, Takada K, Parkin D. Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy. Long-term follow-up of a cohort of 145 patients participating in randomized controlled studies. Arthritis Rheum. 2002;46:995-1002.

Illei GG, Austin III HA, Crane M. Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Ann Intern Med. 2001;135:248-57.

Huong DLT, Amoura Z, Duhaut P. Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients. J Rheumatol. 2002;29:2571-6.

Mok CC, Ho CTK, Chan KW, Lau CS, Wong RWS. Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine. Arthritis Rheum. 2002;46:1003-13.

Ioannidis JPA, Katsifis GE, Tzioufas AG, Moutsopoulos HM. Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus. J Rheumatol. 2002;29:2129-35.

Mok CC, Lau CS, Wong RWS. Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy. Arthritis Rheum. 1998;41:831-7.

Sklar CA, Kim TH, Ramsay NK. Testicular function following bone marrow transplantation performed during or after puberty. Cancer. 1984;53:1498-501.

Sklar CA, Kim TH, Williamson JF, Ramsay NK. Ovarian function after successful bone marrow transplantation in postmenarcheal females. Med Pediatr Oncol. 1983;11:361-4.

Sorror ML, Storer BE, Maloney DG, Sandmaier BM, Martin PJ, Storb R. Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia. Blood. 2008;111:446-52.

Alyea EP, Kim HT, Ho V. Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome. Biol Blood Marrow Transplant. 2006;12:1047-55.

Rodriguez R, Nademanee A, Ruel N. Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin’s lymphoma. Biol Blood Marrow Transplant. 2006;12:1326-34.

Matsumoto M, Shinohara O, Ishiguro H, Shimizu T, Hattori K, Ichikawa M, et al. Ovarian function after bone marrow transplantation performed before menarche. Arch Dis Child. 1999;80:452-4.

Sanders JE, Hawley J, Levy W. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood. 1996;87:3045-52.

Wang WS, Tzeng CH, Hsieh RK, Chiou TJ, Liu JH, Yen CC, et al. Successful pregnancy following very high-dose total body irradiation (1575 cGy) and bone marrow transplantation in a woman with acute myeloid leukemia. Bone Marrow Transplant. 1998;21(4):415-7.